Beazley Share Discussion Threads

[tournesol] 07/2/2013 12:47

I've sold BEZ-B bonds and switched the proceeds plus a bit more into the ords. It looks like the ords might well pay more in divis than the bonds' 5 and a bit % and keep up with inflation too.

I bought ords a few years ago when I noticed that the CEO had bought at around 92p (from memory) and I was pleased to get in at 88p. Unfortunately I sold at 120p and never got round to re-entering. I did subscribe for the BEZ-B bonds which have done what they said on the tin but am now readjusting my risk/reward profile and reckon that the ords look like a very good proposition at this point in the cycle.

[topvest] 07/2/2013 10:35

Great result - quality company.

[dr biotech] 07/2/2013 09:41

My usual strategy is "sell and regret". Thats happened recently with a few.

[edmundshaw] 07/2/2013 09:17

Seems an odd time to sell unless you have a very large position - news is unexpectedly good, I would expect upgrades and a rise from here shortly.

[deadly] 07/2/2013 09:04

Great stuff - glad I bought in on the dip. Still looks cheap after the rise today. Diluted EPS of 26p gives a P/E of only 8 and a historic yield of 5%.
And all this with no stamp duty to pay.

[dr biotech] 07/2/2013 09:02

FWIW I am out of here this morning. Bought these from an IC tip around 140 last year and they have been an excellent investment. Good luck to all those that remain.

[edmundshaw] 07/2/2013 08:44

Super result for the year. And a special divi.

I love the paragraph ending: "The dividend we propose above will ensure that the group's equity capital does not grow beyond our medium term needs. At the same time, the surplus capital we are retaining, backed up by our unutilised debt capacity and strong earnings generation, afford us significant flexibility to take advantage of emerging opportunities. "

Code for "we are rolling in the stuff!" :-)

[deadly] 30/1/2013 17:50

So why the big fall today - any downgrades?

[andrewbaker] 13/12/2012 10:14

These guys will do well from Hurricane Sandy - and any others - as the increase in premiums afterwards more than covers any insured loss payouts: it's the way this works and one way these insurers make money. Buy non-life insurers after a catastrophe, as it's pretty certain their share price will rise as a consequence of this.

[edmundshaw] 09/11/2012 16:37

Good to see the investment yield up from 1% to 2.1% too. Much healthier...

[dr biotech] 09/11/2012 10:22

Seems to be under control - COR of 92% is pretty reassuring.

[edmundshaw] 29/10/2012 13:36

More like, hope the hurricane is not too bad. If there were no hurricanes there would be no business...

[dr biotech] 29/10/2012 11:32

Have to hope they are not to exposed to the impending hurricane - guess that would be their reinsurance business.

[edmundshaw] 20/7/2012 19:51

An easy hold/add for me. Decent yield, well covered, and PE looks good too if they can maintain that combined ratio with their active approach to underwriting.

[dr biotech] 20/7/2012 10:17

Its always been a bit of a slow burner - if they can repeat that full year it would be on a PE of just 6

[edmundshaw] 20/7/2012 10:01

Yes, nice. Market not too interested though... ???

[1nf3rn0] 20/7/2012 07:56

Great H1 results today. EPS 12.5p for the first 6 months and 8% dividend increase.

[dr biotech] 16/7/2012 16:45

Looks like there is some optimism for the results on friday.

[edmundshaw] 11/7/2012 13:54

?? the price is down over 2%. That sort of interest is not generally too helpful.

[andrewbaker] 11/7/2012 11:01

There's significant interest in Beazley today. Somebody thinks there's something afoot ...

[boros10] 13/5/2012 21:49

Barclays Stockbrokers has written to its customers seeking consent for a change which may have adverse consequences for investors who hold in excess of £85,000 in cash.

In the second half of 2012, Barclays Stockbrokers will cease to offer a broking service. Consenting clients will be transferred to Barclays Bank plc ("the Bank") who will offer the same service as at present.

The big potential problem arises from the change in the way cash balances will be treated. At present, cash balances are held as Client Money in accordance
with the FSA's Client Money rules. This means cash is held with regulated banks completely separated from Barclays Stockbrokers own money and assets. No more than 20% of Client Money can be held with banks within the Barclays Bank Group.

In future, cash balances held in broking accounts will be effectively treated as a deposit with Barclays Bank plc. In the event of Barclays Bank plc becoming insolvent Client cash will no longer be ring-fenced from use leaving Clients fully exposed as non-preferential creditors of the Bank.

I have set up a new thread (BROK) for Barclays Stockbrokers' clients affected by these changes and would also welcome contributions from investors using other brokers.

[dr biotech] 11/5/2012 09:02

And a decent director buy this morning too. Assuming that 1.41p is 141p...

[edmundshaw] 10/5/2012 21:25

Ok, you can relax those digits now. Good news...

[dr biotech] 09/5/2012 16:40

Decent rise today ahead of the IMS tomorrow - fingers crossed for no disasters this year.

[dr biotech] 22/3/2012 13:44

Oh right - missed that HDU were "bought" yesterday. Perhaps these will be next.